Stevanato Group S.p.A., a global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology and life sciences industries, expanded its Vertiva platform, which will include a 10mL option to be presented at CPHI Milan. The Vertiva platform is designed to be easy to use and can be pre-programmed to accommodate different motor driven dosing profiles, from micro-precision basal delivery to full-content bolus injections. This platform is ideal for administering a wide range of small molecule and biologic therapies, enabling treatment for conditions such as cardiovascular and metabolic disorders, oncology, immunology, and pain management.
 
The Vertiva platform design features a single-use pod containing a pre-filled, pre-loaded cartridge, paired with a reusable, smart controller that communicates with magnetically coupled drive mechanism. The pod, securely interlocked with the controller, contains a pre-filled glass cartridge available in formats ranging from 3mL up to 10mL and is assembled at the factory for immediate use. 
 
The smart controller provides the option to record patient usage data, which can be transferred via Bluetooth to digital health applications. Additionally, the two-part system allows for easy separation of the reusable controller from the disposable pod after treatment.
 
“We are excited to announce that the Vertiva platform represents a significant breakthrough for the biopharma industry,” said Michele Monico, Vice President, Business Line DDS at Stevanato Group. “By combining sustainable and modular design with versatile delivery capabilities, the move to larger volume capacity extends treatment options for a wider range of therapies, enabling biopharma companies to faster and lower cost stability and clinical evaluations. This advancement will redefine how we approach patient at-home and on-body treatment, paving the way for more adaptable and patient-centered solutions.”
 
Stevanato Group will leverage its capabilities and its existing partnership with Thermo Fisher Scientific to bring Vertiva 10mL to market. Along with the device platform, Stevanato Group will offer its pre-sterilized EZ-fill cartridges as drug containment solutions and assembly equipment, while Thermo Fisher will provide fill-and-finish and final assembly services.